Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

TNF-alpha (tumor necrosis factor-alpha) mutant protein and carrier protein CRM197 chemically coupled product and preparation method thereof

A technology of CRM197 and carrier protein, applied in the fields of biology and medicine, can solve the problems of difference in cross-linking rate, not reaching the theoretical cross-linking rate, etc., and achieve the effect of prolonging survival period, improving immunogenicity and improving quality of life

Inactive Publication Date: 2018-06-08
SHANGHAI HYCHARM
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

From the experimental results, although the chemical cross-linking rate is high, it has not reached the theoretical cross-linking rate, and there are differences in the cross-linking rate of different sugars, which shows that the cross-linking rate is also related to the cross-linked product [Biophysical Journal . 2004, 86(1 Pt 1):3-9.]

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0014] After extensive and in-depth research, the present invention finds that the human TNF-α protein is chemically coupled with the complete CRM197, and after formaldehyde inactivation, the antigen retains immunogenicity, which can effectively stimulate mice to produce antibodies against human TNF-α. The present invention has been accomplished on this basis.

[0015] representative protein

[0016] Tumor necrosis factor alpha (TNF-α)

[0017] Tumor necrosis factor α (tumor necrosis factor alpha) is mainly secreted by activated monocytes or macrophages, and it is also one of the cytokines that cause acute phase reactions while participating in systemic inflammation.

[0018] A single TNF-α molecule consists of two β-sheets, each of which is rich in hydrophilic amino acids on the outside and hydrophobic amino acids on the inside. The three monomers TNF-α form a trimer, and a hydrophobic amino acid pore is formed in the middle, which is significantly different from the polar ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a protein antigen of a vaccine preparation targeting TNF-alpha (tumor necrosis factor-alpha) as well as a preparation method and an application of the protein antigen. Specifically, the protein antigen comprises recombination expression hTNF-alpha (human TNF-alpha) protein and CRM197 which are coupled through glutaraldehyde and inactivated through formaldehyde. The protein antigen almost has no TNF-alpha toxicity in the dosage of a vaccine, reserves the high immunogenicity and can stimulate mice to produce a remarkable immunoreaction targeting hTNF-alpha after being combined with an aluminum hydroxide adjuvant.

Description

technical field [0001] The invention belongs to the field of biology and medicine, and in particular relates to the preparation method and application of tumor necrosis factor alpha (TNF-alpha) vaccine with low biological activity but strong immunogenicity. The antigen prepared by the invention hardly has TNF-α toxicity, but has strong immunogenicity in mice. Background technique [0002] Tumor necrosis factor-α (TNF-α), as an important immune regulatory molecule, plays an important role in physiological and pathological processes such as cell growth, differentiation and death. TNF-α is a cytokine mainly produced by monocytes or macrophages. It can not only selectively kill certain tumor cells, but also has a variety of immune regulation functions. In recent years, studies have found that a variety of human diseases are related to high expression levels of TNF-α in the body, such as autoimmune diseases such as rheumatoid arthritis and malignant tumors. Inhibiting the funct...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K39/385A61K39/39A61P29/00A61P19/02A61P17/06A61P1/00
CPCA61K39/385A61K39/39A61K2039/55505A61K2039/6037
Inventor 周福强张丽叶龙仲从浩程超祝先潮邓立龚小海颜远伟黎荣松徐爱章张舒林李荣秀
Owner SHANGHAI HYCHARM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products